|
Life Science Nation Newsletter | September 11, 2014 | Issue 79
|
|
If You're Serious About Raising Capital, Check Out The RESI Program
|
Who's Meeting Whom at RESI?
|
|
RESI Workshop: The Life Sciences Legal Landscape Funding Boot Camp
|
RESI Panel Announcement: Patient Groups
|
 Life Science Investor Mandates (Sept. 3 - Sept. 9) |
| |
|
|
Seeking Advanced Materials Science
|
Seeking Strategic Life Science Opportunities
|
Seeking Innovative Therapeutics Devices and Healthcare IT
|
|
|
|
By Dennis Ford, Founder & CEO, LSN
 Life Science Nation saw a glaring need to create a Redefining Early Stage Investment Conference (RESI) and launched it just a few years ago. If you are raising capital or contemplating raising capital, then next week's RESI conference is a great opportunity to get in front of investors.This is a genuine opportunity to get feedback on your company and gauge how you are doing with your corporate pitch and positioning . If you are looking for capital in the next 9-18 months this represents a gem of an opportunity. RESI has over 120 investors signed into the partnering system as of today and we expect another 50 to sign up this week and next... Click here to check out the RESI Program! |
 |
|
By Lucy Parkinson, Senior Research Manager, LSN
 With less than a week to go until LSN's Redefining Early Stage Investments (RESI) conference, attendees are using our online partnering system to set up meetings during the event. Registered RESI attendees have sent more than 1,300 meeting requests to each other, resulting in hundreds of partnering meetings already scheduled. As we go into the last week before the conference, there's still bandwidth available for newly registered startups and investors to book meetings. Each attendee is able to book up to 18 meetings, so it's not too late to register and begin filling up your schedule. All attendees belong to one of three broad categories: investors; biotech and medtech companies; or service providers and consultants. With three categories of attendees, the meetings booked fall into six groups. (See Exhibit 1.)... 
|
|
 |
Your company is growing and seeking funding-you have great science that addresses an unmet need and a compelling value proposition! Your product is better, faster and cheaper! But is your legal house in order? The McDermott team will discuss how to navigate through the life sciences legal landscape to help you avoid the common pitfalls experienced by too many life sciences entrepreneurs. From formation and founder issues, to the big three of intellectual property, regulatory and reimbursement, to the complexities of raising capital through crowdfunding and initial public offerings, we will provide you with insights into the latest funding trends and a virtual checklist to assure you are building your company on a firm foundation that will facilitate access to capital and future growth...
|
|
|
|
 Few people, if any, have stronger motivations for the advancement of innovative and effective new therapies than the affected patients and their families and friends. Patient groups are established as a way for these individuals to band together around a particular indication or branch of medicine to help move science forward. Formed by patients and for patients, these groups are looking to improve the standard of care by pooling their capital, scientific resources, and networks to aid in both academic and commercial-stage research.The upcoming RESI Conference will host a patients group panel moderated by Steve Perrin of the ALS Therapy Development Institute. The panel will include the following speakers: - Joe Camaratta, Board Member, Founders Affiliate, American Heart Association
- Annette Bakker, President & CSO, Children's Tumor Foundation
- Steven Young, President & COO, Addario Lung Cancer Medical Institute
- Monica Gow, Executive Director, Wake Up Narcolepsy
|
|
|
|
|
|
|
|
Editors:
Nono Hu, Senior Manager, Branding & Messaging, LSN
|
|
|
|
